UK markets closed

Aurora Cannabis Inc. (ACB.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
1.8900+0.1100 (+6.18%)
At close: 04:00PM EST
Currency in CAD

Valuation measures4

Market cap (intra-day) 612.99M
Enterprise value 568.90M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.93
Price/book (mrq)0.99
Enterprise value/revenue 2.70
Enterprise value/EBITDA -0.35

Trading information

Stock price history

Beta (5Y monthly) 3.01
52-week change 3-75.20%
S&P500 52-week change 3-11.32%
52-week high 38.5200
52-week low 31.3600
50-day moving average 31.7108
200-day moving average 32.6689

Share statistics

Avg vol (3-month) 32.96M
Avg vol (10-day) 32.1M
Shares outstanding 5324.33M
Implied shares outstanding 6N/A
Float 8307.49M
% held by insiders 10.08%
% held by institutions 120.99%
Shares short (14 Nov 2022) 48.82M
Short ratio (14 Nov 2022) 42.79
Short % of float (14 Nov 2022) 4N/A
Short % of shares outstanding (14 Nov 2022) 42.72%
Shares short (prior month 13 Oct 2022) 47.17M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 310 May 2020
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 310 May 2020

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2022
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)-110.87%

Management effectiveness

Return on assets (ttm)-7.82%
Return on equity (ttm)-134.22%

Income statement

Revenue (ttm)210.49M
Revenue per share (ttm)0.88
Quarterly revenue growth (yoy)-18.00%
Gross profit (ttm)21.23M
EBITDA -169.89M
Net income avi to common (ttm)-1.76B
Diluted EPS (ttm)-6.1050
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)369.65M
Total cash per share (mrq)1.14
Total debt (mrq)325.57M
Total debt/equity (mrq)54.76
Current ratio (mrq)4.07
Book value per share (mrq)1.85

Cash flow statement

Operating cash flow (ttm)-118.3M
Levered free cash flow (ttm)-111.79M